Effect of hormone replacement therapy in matrix metalloproteinase expression and intimal hyperplasia development after vascular injury

Annals of Vascular Surgery

Volumn 27, Issue 3, 2013, Pages 337-345

  Mountain, Deidra J H ^a   Freeman, Michael B ^a   Kirkpatrick, Stacy S ^a   Cook, Richard B ^a   Chalk, James E ^a   Stevens, Scott L ^a   Goldman, Mitchell H ^a   Grandas, Oscar H ^a  

^a UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELASTIN; ESTROGEN; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; PLACEBO; PROGESTERONE; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; IN VIVO STUDY; NONHUMAN; OVARIECTOMY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRICHOME;

ANGIOPLASTY, BALLOON; ANIMALS; CAROTID ARTERY INJURIES; CAROTID ARTERY, COMMON; DISEASE MODELS, ANIMAL; DRUG IMPLANTS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HYPERPLASIA; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOINTIMA; OVARIECTOMY; PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; VASCULAR SYSTEM INJURIES;

EID: 84875219031     PISSN: 08905096     EISSN: 16155947     Source Type: Journal    
DOI: 10.1016/j.avsg.2012.05.010     Document Type: Article

References (34)

1. M.E. Mendelsohn, and R.H. Karas Molecular and cellular basis of cardiovascular gender differences Science 308 2005 1583 1587
2. V. Cheanvechai, N.L. Harthun, and L.M. Graham Incidence of peripheral vascular disease in women: is it different from that in men? J Thorac Cardiovasc Surg 127 2004 314 317
3. C.H. Timaran, S.L. Stevens, and O.H. Grandas Influence of hormone replacement therapy on graft patency after femoropopliteal bypass grafting J Vasc Surg 32 2000 506-16, 516-18
4. C.H. Timaran, S.L. Stevens, and O.H. Grandas Influence of hormone replacement therapy on the outcome of iliac angioplasty and stenting J Vasc Surg 33 suppl 2001 S85 S92
5. M.P. Bendeck, C. Irvin, and M.A. Reidy Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury Circ Res 78 1996 38 43
6. N. Zempo, N. Koyama, and R.D. Kenagy Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor Arterioscler Thromb Vasc Biol 16 1996 28 33
7. J. Cao, H. Sato, and T. Takino The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation J Biol Chem 270 1995 801 805
8. H. Sato, T. Kinoshita, and T. Takino Activation of a recombinant membrane. type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2 FEBS Lett 393 1996 101 104
9. H. Nagase, K. Suzuki, and T.E. Cawston Involvement of a region near valine-69 of tissue inhibitor of metalloproteinases (TIMP)-1 in the interaction with matrix metalloproteinase 3 (stromelysin 1) Biochem J 325 1997 163 167
10. H. Nagase, and J.F. Woessner Jr. Matrix metalloproteinases J Biol Chem 274 1999 21491 21494
11. M.J. Hobeika, R.W. Thompson, and B.E. Muhs Matrix metalloproteinases in peripheral vascular disease J Vasc Surg 45 2007 849 857
12. Z.S. Galis, and J.J. Khatri Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly Circ Res 90 2002 251 262
13. O.H. Grandas, D.J. Mountain, and S.S. Kirkpatrick Effect of hormones on matrix metalloproteinases gene regulation in human aortic smooth muscle cells J Surg Res 148 2008 94 99
14. O.H. Grandas, D.H. Mountain, and S.S. Kirkpatrick Regulation of vascular smooth muscle cell expression and function of matrix metalloproteinases is mediated by estrogen and progesterone exposure J Vasc Surg 49 2009 185 191
15. D.J. Mountain, S.S. Kirkpatrick, and M.B. Freeman Role of MT1-MMP in estrogen-mediated cellular processes of intimal hyperplasia J Surg Res 173 2012 224 231
16. W.J. Tsai, K.M. McCormick, and D.A. Brazeau Estrogen effects on skeletal muscle insulin-like growth factor 1 and myostatin in ovariectomized rats Exp Biol Med (Maywood) 232 2007 1314 1325
17. M. Ernst, C. Schmid, and E.R. Froesch Phenol red mimics biological actions of estradiol: enhancement of osteoblast proliferation in vitro and of type I collagen gene expression in bone and uterus of rats in vivo J Steroid Biochem 33 1989 907 914
18. B. Ramachandran, S. Makela, and J.P. Cravedi Estrogen-like effects of diet-derived cadmium differ from those of orally administered CdCl(2) in the ERE-luc estrogen reporter mouse model Toxicol Lett 202 2011 75 84
19. F.J. Steyn, G.M. Anderson, and D.R. Grattan Differential effects of centrally-administered oestrogen antagonist ICI-182,780 on oestrogen-sensitive functions in the hypothalamus J Neuroendocrinol 19 2007 26 33
20. K. Palmer, and J.M. Gray Central vs. peripheral effects of estrogen on food intake and lipoprotein lipase activity in ovariectomized rats Physiol Behav 37 1986 187 189
21. H.M. Rivera, and L.A. Eckel Activation of central, but not peripheral, estrogen receptors is necessary for estradiol's anorexigenic effect in ovariectomized rats Endocrinology 151 2010 5680 5688
22. T. Eugster, L. Gurke, and T. Obeid Infrainguinal arterial reconstruction: female gender as risk factor for outcome Eur J Vasc Endovasc Surg 24 2002 245 248
23. M.A. Enzler, M. Ruoss, and B. Seifert The influence of gender on the outcome of arterial procedures in the lower extremity Eur J Vasc Endovasc Surg 11 1996 446 452
24. M. Canonico, C. Straczek, and E. Oger Postmenopausal hormone therapy and cardiovascular disease: an overview of main findings Maturitas 54 2006 372 379
25. T. Ishibahshi, S. Obayashi, and S. Sakamoto Estrogen replacement effectively improves the accelerated intimal hyperplasia following balloon injury of carotid artery in the ovariectomized rats J Cardiovasc Pharmacol 47 2006 37 45
26. G. Finking, N. Krauss, and S. Romer 17beta-estradiol, gender independently, reduces atheroma development but not neointimal proliferation after balloon injury in the rabbit aorta Atherosclerosis 154 2001 39 49
27. R.L. Geary, M.R. Adams, and M.E. Benjamin Conjugated equine estrogens inhibit progression of atherosclerosis but have no effect on intimal hyperplasia or arterial remodeling induced by balloon catheter injury in monkeys J Am Coll Cardiol 31 1998 1158 1164
28. A.P. Miller, D. Xing, and W. Feng Aged rats lose vasoprotective and anti-inflammatory actions of estrogen in injured arteries Menopause 14 2007 251 260
29. M.P. Bendeck Matrix metalloproteinases: are they antiatherogenic but proaneurysmal? Circ Res 90 2002 836 837
30. Z.S. Galis, G.K. Sukhova, and M.W. Lark Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques J Clin Invest 94 1994 2493 2503
31. S. Filippov, G.C. Koenig, and T.H. Chun MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells J Exp Med 202 2005 663 671
32. M.A. Tummers, D.J. Mountain, and J.W. Mix Serum levels of matrix metalloproteinase-2 as a marker of intimal hyperplasia J Surg Res 160 2010 9 13
33. C.S. Wingrove, E. Garr, and I.F. Godsland 17beta-oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells Biochim Biophys Acta 1406 1998 169 174
34. E.Y. Liao, X.H. Luo, and X.G. Deng Effects of 17beta-estradiol on the expression of membrane type 1 matrix metalloproteinase (MT1-MMP) and MMP-2 in human osteoblastic MG-63 cell cultures J Endocrinol Invest 24 2001 876 881